Boardroom Alpha
Research library
SPACs · Oct 16, 2026

SPAC Market Update October 16, 2026: PAII-Sakuu Merger Agreement, TCXB $100M IPO

Pyrophyte Acquisition Corp II (PAII) announced a merger agreement with Sakuu Corp on October 15, 2026; no transaction dollar value was disclosed. Separately, TCGX Acquisition Corp. II (TCXB) priced a $100M IPO on October 16, 2026 targeting biotech…

SPAC IPO Update — October 16, 2026

1 SPAC IPO priced on October 16, 2026, raising $100M; October MTD now stands at 4 IPOs totaling $491M over 16 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 4•Prior: 5•MoM: -1
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
4
Oct ’26
Source: Boardroom Alpha
IPO Activity Snapshot1 SPAC IPO today raising $100M · TCXB ($100M)
Month-to-date: 4 IPOs ($491M) vs. first 16 days of last month 1 ($100M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
Size
$100M
Ticker
Sponsor
TCGX Sponsor II, LLC

TCGX Acquisition Corp. II is targeting biotech opportunities, with a focus on assets sourced from China. The company aims to leverage its management’s expertise in life sciences and its established presence in both U.S. and Asia markets.

Leadership
Chen YuCEO, Director
Founder of TCGX with over two decades in healthcare investing; led investments in companies like CRISPR Therapeutics and Zai Labs.
Craig SkalingCFO, Director
CFO and COO of TCGX; former Director of Finance at Vetamer Capital Management.
Joshua B CohenDirector
Co-founder and co-CEO of Amylyx Pharmaceuticals, leading it through global regulatory approval and commercialization.
Mark C McKennaDirector
CEO of Mirador Therapeutics and venture partner at ARCH Venture Partners; former CEO of Prometheus Biosciences.
Michael C HendersonDirector
CEO of Paragon Laboratories; former Chief Business Officer at BridgeBio Pharma.
Chen-Ming YuDirector
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 16 TCXB TCGX Acquisition Corp. II $100M 100.0%
Oct 14 FLSC FRAZIER LIFE SCIENCES ACQUISITION CORP II $75M 100.0%
Oct 06 PAXG PINE TREE ACQUISITION CORP $100M  $6M overallotment 100.0%
Source: Boardroom Alpha

Daily SPAC Update — October 16, 2026

SPAC VOTE RESULTS
EVEREST CONSOLIDATOR ACQUISITION CORP (MNTN1) * Extend to December 31, 2027

SPAC DEALS ANNOUNCED
October 15 | Pyrophyte Acquisition Corp II (PAII) + Sakuu CorpSakuu Corp provides commercial-scale printing equipment and technologies for manufacturers of batteries, electrodes, and supercapacitors. Its Kavian Platform enables dry printing of battery electrodes, promoting rapid manufacturing while reducing costs and waste. Headquartered in Silicon Valley, it focuses on sustainable manufacturing solutions.
October 13 | Horizon Space Acquisition I Corp (HSPOF) + ArcheNova Biotech CorpArcheNova Biotech Corp is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of drugs derived from MSC-derived extracellular vesicles and exosomes. It is advancing five product candidates across various therapeutic areas, including dermatology, orthopedics, ophthalmology, neurology, and cardiology. Its lead candidate for psoriasis has completed a Phase I study and is preparing for a Phase II trial.

SPAC DEAL & EXTENSION VOTES SET
Climaterock (CLRCF) * EXTENSION VOTE SET: October 29, 2026 * trust $13.38
Cactus Acquisition Corp 1 Ltd (CCTSF) * EXTENSION VOTE SET: October 27, 2026 * trust $12.60

SPAC EXTENSIONS
ATHENA TECHNOLOGY ACQUISITION CORP II (ATEK) * Extension FilingAthena Technology Acquisition Corp. II extends its deadline to November 14, 2026, with a $271.48 deposit into the trust.

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-10-09: COPL + Ignite Proteomics Holdings,

OTHER SPAC NEWS
OAKTREE ACQUISITION CORP III LIFE SCIENCES (OACC) * Vote PostponedOaktree Acquisition Corp. III Life Sciences postpones the general meeting to Oct 23, 2026 to extend the business combination deadline.
OAKTREE ACQUISITION CORP III LIFE SCIENCES (OACC) * Redemption Update * 13,326,977 redeemedOaktree Acquisition III Life Sciences extends the extension. 13.33M Class A redeemed; sponsor converts B to A founder shares.
PYROPHYTE ACQUISITION CORP II (PAII) * Merger Agreement
SPACSPHERE ACQUISITION CORP (SSAC) * Merger Agreement AmendmentAmendment to BCA expands the board to seven, adding two company-designated directors and four independents.

SPAC Executive & Director Moves — October 16, 2026

SPAC Executive & Director Moves
Company Ticker Moves
CANTOR EQUITY PARTNERS VII INC CAES
  • Alan Riffkin entered the board of Cantor Equity Partners VII, Inc. as a Class I director effective October 14, 2026, and also joined the audit and compensation committees. He will receive $50,000 annually, paid quarterly, for board service.  (view source)
CANTOR EQUITY PARTNERS V INC CEPV
  • Robert Hochberg was appointed to the Board of Cantor Equity Partners V, Inc. as a Class II director effective October 14, 2026, and appointed to the audit and compensation committees. He will receive $50,000 annually, paid quarterly, and is currently President and CEO of Numeric Computer Systems, Inc.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — October 16, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RF ACQUISITION CORP II RFAI 13.1% $ 34.00 Announced
FUTURE VISION II ACQUISITION CORP FVN 8.3% $ 9.50 Announced
XFLH CAPITAL CORP XFLH 7.7% $ 10.88 Pre-Deal
CALISA ACQUISITION CORP ALIS 4.8% $ 8.93 Announced
CHURCHILL CAPITAL CORP XI CCXI 4.8% $ 11.35 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
ARCHIMEDES TECH SPAC PARTNERS II CO ATII -11.9% $ 8.86 Announced
BLACK HAWK ACQUISITION CORP BKHA -11.5% $ 6.85 Announced
RIBBON ACQUISITION CORP RIBB -6.2% $ 6.20 Announced
TCGX ACQUISITION CORP TCGX -4.0% $ 12.36 Pre-Deal
OAKTREE ACQUISITION CORP III LIFE SCIENCES OACC -2.6% $ 10.65 Pre-Deal
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What did Pyrophyte Acquisition Corp II announce with Sakuu Corp?
    Pyrophyte Acquisition Corp II (PAII) announced a merger agreement with Sakuu Corp on October 15, 2026. Sakuu provides commercial-scale printing equipment and technologies for battery, electrode and supercapacitor manufacturers.
  • Which SPAC IPO priced on October 16, 2026?
    TCGX Acquisition Corp. II (TCXB) priced a $100M IPO on October 16, 2026. The SPAC is targeting biotech opportunities, with a focus on assets sourced from China.
  • How many SPAC IPOs priced in October 2026 through October 16?
    4 SPAC IPOs priced for $491M through October 16, 2026, compared with 1 IPO for $100M over the same first 16 days of September 2026.
  • Which extension votes were set today?
    Climaterock (CLRCF) set an extension vote for October 29, 2026. Cactus Acquisition Corp 1 Ltd (CCTSF) set an extension vote for October 27, 2026.
  • What was the Everest Consolidator Acquisition Corp vote result?
    Everest Consolidator Acquisition Corp (MNTN1) received approval to extend its deadline to December 31, 2027; the source data did not provide redemption share or dollar figures.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 16, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer